Table 1 Novel clinical trials (CTs) in phase II/III, phase III, phase II/IV or phase IV (n = 71) (note that phase II/IV and phase IV trials all fell in the drug treatments, stents or other categories (n = 17))
From: Is belief larger than fact: expectations, optimism and reality for translational stem cell research
Clinical trial subject | No. of CTs | Country |
|---|---|---|
Bone conditions | 3 | Iran, USA |
Cardiovascular disease | 29 | Brazil, Canada, China, Finland, Germany, India, Iran, Italy, Mexico, The Netherlands, Russia, South Korea, UK, USA |
Cartilage damage | 2 | Egypt, South Korea |
Crohn's Disease | 4 | UK, USA |
Diabetes | 2 | India, China |
Multiple sclerosis | 1 | USA |
Ocular surface disease | 2 | Malaysia, Thailand |
Scleroderma | 3 | USA |
Spinal cord injury | 1 | India |
Drug treatments for stem cell mobilization | 11 | China, Germany, Italy, South Korea, Turkey, USA |
Stents for capturing endothelial progenitor cells | 3 | China, The Netherlands, Poland |
Other (mainly graft-versus-host disease) | 3 | India, Germany, UK |